These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 853542)

  • 1. A prospective on covalent binding and toxicity.
    Gillette JR; Pohl LR
    J Toxicol Environ Health; 1977 Mar; 2(4):849-71. PubMed ID: 853542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state of the art: a commentary on the current practice of metabolism and pharmacokinetic studies in the pharmaceutical industry.
    Case DE
    Xenobiotica; 1981 Dec; 11(12):803-14. PubMed ID: 7342486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in chronic animal toxicity studies.
    Yacobi A; Kamath BL; Lai CM
    Drug Metab Rev; 1982; 13(6):1021-51. PubMed ID: 6754316
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability of residues: current status.
    Huber WG; Becker SR; Archer BP
    J Environ Pathol Toxicol; 1980; 3(5-6):45-63. PubMed ID: 7003045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and toxicity testing.
    Clark B; Smith DA
    Crit Rev Toxicol; 1984; 12(4):343-85. PubMed ID: 6378530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodology for the determination of bioavailability of labeled residues.
    Gallo-Torres HE
    J Toxicol Environ Health; 1977 Mar; 2(4):827-45. PubMed ID: 857043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of overloading pathways on toxicity.
    Wolf FJ
    J Environ Pathol Toxicol; 1980; 3(5-6):113-34. PubMed ID: 7441076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and metabolic studies in the development of drugs].
    Vereczkey L
    Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated pharmacokinetic-dynamic modeling of drugs acting on the CNS.
    Paalzow LK
    Drug Metab Rev; 1984; 15(1-2):383-400. PubMed ID: 6378561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, disposition, and toxicity of drugs and other xenobiotics in aquatic species.
    Guarino AM; Lech JJ
    Vet Hum Toxicol; 1986; 28 Suppl 1():38-44. PubMed ID: 3334693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioavailability of drugs--concepts and problems].
    Bekemeier H; Hirschelmann R
    Pharmazie; 1984 Jan; 39(1):59-62. PubMed ID: 6718470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bound residues of veterinary drugs: bioavailability and toxicological implications.
    Burgat-Sacaze V; Delatour P; Rico A
    Ann Rech Vet; 1981; 12(3):277-89. PubMed ID: 7344560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of non-linear (dose-dependent) pharmacokinetics in hazard assessment.
    Watanabe PG; Young JD; Gehring PJ
    J Environ Pathol Toxicol; 1977; 1(2):147-59. PubMed ID: 553128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicological significance of covalently-bound residues.
    Rico AG; Burgat-Sacaze V
    Food Addit Contam; 1984; 1(2):157-61. PubMed ID: 6536527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic considerations in toxicity testing.
    Jollow DJ; Roberts S; Price V; Longacre S; Smith C
    Drug Metab Rev; 1982; 13(6):983-1007. PubMed ID: 6754320
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability and safety of nonextractable bound drug-related residues.
    Sieck RF
    J Toxicol Environ Health; 1977 Mar; 2(4):847. PubMed ID: 853541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Capacity limited pharmacokinetics, a mechanism of drug toxicity (author's transl)].
    Dettli L
    Arzneimittelforschung; 1977; 27(96):1844-8. PubMed ID: 579151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.